Grey Zone Series
The guidelines can define the risks. They don’t always tell you what to do next.
Practical frameworks, longitudinal cases, and point-of-care tools for clinical decisions that resist simple algorithms.
One connected approach
Learn the framework. Follow the cases. Apply it in clinic.
Each Grey Zone series uses the same three-part structure. The scope may change by topic, but the goal stays the same: turn clinical complexity into a practical way forward.
Core Framework
Organize the evidence, risks, pharmacology, and clinical tradeoffs into a coherent approach to the problem.
Case Series
Follow the reasoning across realistic cases, including what was tried, what changed the plan, and where each case landed.
Clinical Toolkit
Move from the larger framework to concise answers, clinician references, patient handouts, and tools you can use at the point of care.
Available now
Benzodiazepines in the Grey Zone
A Case Series + Clinical Toolkit
A practical system for deciding what to do when clinical benefit, physical dependence, safety concerns, substance use, and real-world constraints pull in different directions.
Designed for mental health and addiction providers, as well as for primary care clinicians who regularly manage complex benzodiazepine decisions.
Inside the series
Core Framework
Prescribing, reassessment, dependence, withdrawal, tapering, and substance-use complexity.
Grey Zone Cases
Multi-visit cases that make the decision-making visible rather than presenting only the endpoint.
Clinical Toolkit
Interactive answers, clinician references, and patient handouts organized around the question in front of you.
Core Framework and Case Series audio can also be accessed through a private podcast feed.
Beyond the fundamentals
Built for the next layer of clinical judgment.
These are not broad introductions to a diagnosis or medication class. Foundational concepts are reviewed where they matter, but the emphasis is on what happens after the guideline has narrowed the options without choosing among them.
The aim is not certainty where certainty does not exist. It is a clearer, more defensible process for integrating evidence, patient priorities, safety, function, and the realities of longitudinal care.
A growing collection
More grey zones will follow.
Future series may be broader or more focused depending on the clinical problem. Each will retain the same connection between underlying framework, real cases, and practical tools for use in clinic.